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We concur that additional research is needed to improve depression diagnostic algorithms, including validation studies in which gold standard diagnoses are derived from structured interviews. We also agree that caution is warranted when identifying depression in patient populations in which depressive symptoms are not routinely monitored. As recommended by Townsend and colleagues, 3 our depression outcome was identified in a health care system (Veterans Health Administration) in which annual screening is standard of care. We employed a published algorithm 4 with high positive predictive value (84 %) that required two or more outpatient diagnoses or one inpatient diagnosis for depression in the same 12-month period.
Jackson and Gagne 1 raise the possibility that propensity scores (PS) may not reflect treatment decisions when predictors of opioid therapy in the PS model include those measured up to onset of depression. In an ongoing study of OAU, depression, and incident heart disease, we are using PS models with predictors of opioid therapy up to the time of opioid initiation. These PS models perform as well as those using predictors of opioid therapy up to the time of disease onset in balancing patient characteristics across opioid treatment status. Additional information about propensity score (PS) weight distributions from our published analyses 2 is provided in the next paragraph. suggestions, a mean of 1.0 with overall range from 0.18 to 6.91 is consistent with assumptions of PS weighting without bias due to truncating.
We believe that growing sophistication in methods and measurement will expand the use of observational cohorts and advance evidence-based medicine. Indeed, Jackson and Gagne point to the fact that observational cohort designs using medical record data can be the preferred choice over randomized controlled trials (RCTs) when alternative methods are unethical or not feasible in terms of time and money.
